Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for lysosomal storage diseases.

T M Daly1, M S Sands

  • 1Department of Pathology, Washington University School of Medicine, St Louis, MO 63110, USA.

Expert Opinion on Investigational Drugs
|July 5, 2005
PubMed
Summary

Lysosomal storage diseases result from enzyme deficiencies, causing cellular buildup. Gene therapy offers a promising treatment approach by addressing the underlying genetic defects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Macrophage secretion of miR-106b-5p causes renin-dependent hypertension.

Nature communications·2020
Same author

Spinal manifestations of CLN1 disease start during the early postnatal period.

Neuropathology and applied neurobiology·2020
Same author

Validation of a panel of ADAMTS13 assays for diagnosis of thrombotic thrombocytopenic purpura: activity, functional inhibitor, and autoantibody test.

International journal of laboratory hematology·2016
Same author

Validation of a molecular diagnostic assay for CALR exon 9 indels in myeloproliferative neoplasms: identification of coexisting JAK2 and CALR mutations and a novel 9 bp deletion in CALR.

International journal of laboratory hematology·2016
Same author

Trends and Patterns in Reporting of Patient Safety Situations in Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain.

Gene therapy·2013

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Lysosomal storage diseases (LSDs) are inherited disorders caused by single lysosomal enzyme deficiencies.
  • These diseases lead to progressive intralysosomal storage and affect approximately 1 in 3,000 live births, with variable severity.
  • Current treatments are limited to supportive care and genetic counseling.

Purpose of the Study:

  • To describe the biochemical and molecular basis of gene therapy for LSDs.
  • To provide an overview of in vitro and in vivo studies on gene therapy for LSDs.

Main Methods:

  • Review of existing literature on gene therapy strategies for LSDs.
  • Analysis of biochemical and molecular mechanisms underlying gene therapy approaches.
  • Summary of findings from in vitro and in vivo experimental studies.

Main Results:

  • Gene therapy holds potential for treating LSDs by correcting the enzymatic defects.
  • Numerous in vitro and in vivo studies demonstrate the feasibility and efficacy of gene therapy for various LSDs.
  • Advances in gene transfer and expression technologies are crucial for successful gene therapy implementation.

Conclusions:

  • Gene therapy represents a viable therapeutic strategy for lysosomal storage diseases.
  • Further research and clinical translation are needed to fully realize the potential of gene therapy for LSDs.
  • Understanding the genetic basis of LSDs is key to developing effective gene-based treatments.

Related Experiment Videos